Randomized controlled trial comparing gastrectomy Plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan clinical oncology group study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01

Japanese Journal of Clinical Oncology

Volumn 38, Issue 7, 2008, Pages 504-506

  Fujitani, Kazumasa ^a   Yang, Han Kwang ^b   Kurokawa, Yukinori ^a   Park, Do Joong ^c   Tsujinaka, Toshimasa ^a   Park, Byung Joo ^b   Fukuda, Haruhiko ^d   Noh, Sung Hoon ^e   Boku, Narikazu ^f   Bang, Yung Jue ^b   Sasako, Mitsuru ^g   Lee, Jong Inn ^h  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Seoul National University   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d NATIONAL CANCER CENTER   (Japan)

^e Yonsei University College of Medicine   (South Korea)

^f SHIZUOKA CANCER CENTER   (Japan)

^g HYOGO COLLEGE OF MEDICINE   (Japan)

^h Korea Animal Cancer Center   (South Korea)

Author keywords

Advanced gastric cancer; Chemotherapy; Gastrectomy; Non curable factor; Randomized controlled trial

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; GASTRECTOMY; HUMAN; INTERMETHOD COMPARISON; JAPAN; MAJOR CLINICAL STUDY; METHODOLOGY; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SOUTH KOREA; STOMACH CANCER;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CLINICAL PROTOCOLS; GASTRECTOMY; HUMANS; JAPAN; KOREA; MIDDLE AGED; PATIENT SELECTION; RESEARCH DESIGN; STOMACH NEOPLASMS;

EID: 48849110460     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn058     Document Type: Article

References (11)

1. Hartgrink HH, Putter H, Kranenbarg EK, Bonenkamp JJ, van de Velde CJH, for the Dutch Gastric Cancer Group. Value of palliative resection in gastric cancer. Br J Surg 2002;89:1438-43.
2. Bonenkamp JJ, Sasako M, Hermans J, van de Velde CJH. Tumor load and surgical palliation in gastric cancer. Hepato Gastroenterol 2001;48:1219-21.
3. Kikuchi S, Arai Y, Morise M, Kobayashi N, Tsukamoto H, Shimao H, et al. Gastric cancer with metastases to the distant peritoneum: A 20-year surgical experience. Hepato Gastroenterol 1998;45:1183-8.
4. Ouchi Y, Sugawara T, Ono H, Fujiya T, Kamiyama Y, Kakugawa Y, et al. Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 1998;69:41-44.
5. Maekawa S, Saku M, Maehara Y, Sadanaga N, Ikejiri K, Anai H, et al. Surgical treatment for advanced gastric cancer. Hepato Gastroenterol 1996;43:178-86.
6. Haugstvedt T, Viste A, Eide GE, Real C, Soreide O, Members of the norwegian stomach cancer trial. The survival benefit of resection in patients with advanced stomach cancer: The norwegian multicenter experience. World J Surg 1989;13:617-22.
7. Bozzetti F, Bonfanti G, Audisio RA, Doci R, Dossena G, Gennari L, et al. Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet 1987;164:151-4.
8. Meijer S, De Bakker OJGB, Hoitsma HFW. Palliative resection in gastric cancer. J Surg Oncol 1983;23:77-80.
9. Koga. S, Kawaguchi H, Kishimoto H, Tanaka K, Miyano Y, Kimura O, et al. Therapeutic significance of noncurative gastrectomy for gastric cancer with liver metastasis. Am J Surg 1980;140:356-9.
10. Narahara H, Koizumi W, Hara T, Takagane A, Akiya T, Takagi M, et al. Randomized phase III study of S-1 alone versus S-1 + cisplatin in the treatment for advanced gastric cancer (The SPIRITS trial) SPIRITS: S-1 plus cisplatin vs S-1 in RCT in the treatment for stomach cancer. ASCO Proc 2007;25:4514.
11. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma, 2nd edn. Gastric Cancer 1998;1:10-24.